Vor Bio Reports Third Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire · Oct 30, 2026
Kazia Therapeutics to Participate in Fireside Chat at Guggenheim 3rd Annual Healthcare Innovation Conference Cision · Oct 29, 2026
Insmed Reports Third-Quarter 2026 Financial Results and Provides Business Update Cision · Oct 29, 2026
REGENXBIO to Host Conference Call on November 5 to Discuss Third Quarter 2026 Financial Results and Operational Highlights Cision · Oct 29, 2026
Virax Biolabs Appoints Three Distributors for ImmuneSelect Research Products in Mainland China Cision · Oct 29, 2026
Voyager’s Tau-Targeted Gene Therapy VY1706 and Anti-Tau Antibody VY7523 for Alzheimer’s Disease to Be Featured in Poster Presentations at CTAD 2026 Globe Newswire · Oct 27, 2026
Citius Oncology Reports Continued Institutional Demand and 120% Growth in Shipments of LYMPHIR® Units to U.S. Wholesalers During the Fiscal Fourth Quarter of 2026 Cision · Oct 27, 2026
Atrium Therapeutics Doses First Patient in Corventis™, the First Interventional Clinical Trial for People Living with PRKAG2 Syndrome Cision · Oct 27, 2026
